Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Burn

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Rheumatology (Oxford, England)|December 28, 2020
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort studyJennifer C E Lane, James Weaver, Kristin Kostka, et al.
BMC Medical Research Methodology|January 31, 2022
Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international networkRoss D Williams, Aniek F Markus, Cynthia Yang, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Deep phenotyping of 34,128 patients hospitalised with COVID-19 and a comparison with 81,596 influenza patients in America, Europe and Asia: an international network studyEdward Burn, Seng Chan You, Anthony Sena, et al.
The Lancet. Rheumatology|September 1, 2020
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective studyJennifer C E Lane, James Weaver, Kristin Kostka, et al.
Nature Communications|October 7, 2020
Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network studyEdward Burn, Seng Chan You, Anthony G Sena, et al.
Research Square|March 10, 2021
Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDISDaniel Prieto-Alhambra, Kristin Kostka, Talita Duarte-Salles, et al.
Clinical Epidemiology|March 29, 2022
Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDISKristin Kostka, Talita Duarte-Salles, Albert Prats-Uribe, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Rheumatology (Oxford, England)|December 28, 2020
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort studyJennifer C E Lane, James Weaver, Kristin Kostka, et al.
BMC Medical Research Methodology|January 31, 2022
Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international networkRoss D Williams, Aniek F Markus, Cynthia Yang, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Deep phenotyping of 34,128 patients hospitalised with COVID-19 and a comparison with 81,596 influenza patients in America, Europe and Asia: an international network studyEdward Burn, Seng Chan You, Anthony Sena, et al.
The Lancet. Rheumatology|September 1, 2020
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective studyJennifer C E Lane, James Weaver, Kristin Kostka, et al.
Nature Communications|October 7, 2020
Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network studyEdward Burn, Seng Chan You, Anthony G Sena, et al.
Research Square|March 10, 2021
Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDISDaniel Prieto-Alhambra, Kristin Kostka, Talita Duarte-Salles, et al.
Clinical Epidemiology|March 29, 2022
Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDISKristin Kostka, Talita Duarte-Salles, Albert Prats-Uribe, et al.
Pageof 8